LOCUS OF CONTROL AND COLLEGE WOMEN'S ROLE EXPECTATIONS.MARECEK J; FRASCH C.1977; J. COUNSELG PSYCHOL.; U.S.A.; DA. 1977; VOL. 24; NO 2; PP. 132-136; BIBL. 10 REF.Article

Production and control of Neisseria meningitidis vaccinesFRASCH, C. E.Advances in biotechnological processes. 1990, Vol 13, pp 123-145, issn 0736-2293Article

Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriersGAYATHRI ARAKERE; FRASCH, C. E.Infection and immunity. 1991, Vol 59, Num 12, pp 4349-4356, issn 0019-9567Article

Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse modelLI YA WANG; FRASCH, C. E.Infection and immunity. 1984, Vol 16, Num 2, pp 408-414, issn 0019-9567Article

Sudden-onset deafness: serodiagnosis of recent meningococcal infectionKLINE, M. W; FRASCH, C. E.Clinical pediatrics. 1989, Vol 28, Num 11, pp 529-532, issn 0009-9228Article

A method for purification of bacterial R-type lipopolysaccharides (lipooligosaccharides)LIHUA WU; CHAO-MING TSAI; FRASCH, C. E et al.Analytical biochemistry. 1987, Vol 160, Num 2, pp 281-289, issn 0003-2697Article

Specificity of human antibodies reactive with pneumococcal C polysaccharideFRASCH, C. E; CONCEPCION, N. F.Infection and immunity. 2000, Vol 68, Num 4, pp 2333-2337, issn 0019-9567Article

Spectrum of disease due to Haemophilus influenzae type b occurring in vaccinated childrenHINER, E. E; FRASCH, C. E.The Journal of infectious diseases. 1988, Vol 158, Num 2, pp 343-348, issn 0022-1899Article

Involvement of phospholipid end groups of group C Neisseria meningitidis and Haemophilus influenzae type B polysaccharides in association with isolated outer membranes and in immunoassaysARAKERE, G; LEE, A. L; FRASCH, C. E et al.Journal of bacteriology. 1994, Vol 176, Num 3, pp 691-695, issn 0021-9193Article

Expression of Neisseria meningitidis iron-regulated outer membrane proteins, inclunding a 70-kilodalton transferrin receptor, and their potential for use as vaccinesVANERJEE-BHATNAGAR, N; FRASCH, C. E.Infection and immunity. 1990, Vol 58, Num 9, pp 2875-2881, issn 0019-9567Article

Inhibition enzyme-linked immunosorbent assay for serotyping of group B streptococcal isolatesARAKERE, G; FLORES, A. E; FERRIERI, P et al.Journal of clinical microbiology (Print). 1999, Vol 37, Num 8, pp 2564-2567, issn 0095-1137Article

Serotypes and polyacrylamide gel electrophoresis types among disease-associated isolates of group B Neisseria meningitidis in spain, 1976-1979MOCCA, L. F; DEL REAL, G; FRASCH, C. E et al.The Journal of infectious diseases. 1983, Vol 148, Num 2, pp 249-253, issn 0022-1899Article

Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypesFRASCH, C. E; ZOLLINGER, W. D; POOLMAN, J. T et al.Reviews of infectious diseases. 1985, Vol 7, Num 4, pp 504-510, issn 0162-0886Article

Characterization of a stress protein from group B Neisseria meningitidisARAKERE, G; KESSEL, M; NGUYEN, N et al.Journal of bacteriology. 1993, Vol 175, Num 11, pp 3664-3668, issn 0021-9193Article

Immunotype epitopes of Neisseria meningitidis lipooligosaccharide types 1 through 8CHAO-MING TSAI; MOCCA, L. F; FRASCH, C. E et al.Infection and immunity. 1987, Vol 55, Num 7, pp 1652-1656, issn 0019-9567Article

Longitudinal studies of miningococcal carriage during a groupe B epidemicCOETZEE, G. J; FRASCH, C. E; MOCCA, L. F et al.Médecine tropicale. 1983, Vol 43, pp 43-46, issn 0025-682X, h. ser. no 1Article

Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccinesZOLLINGER, W. D; MORAN, E. E; DEVI, S. J. N et al.Infection and immunity. 1997, Vol 65, Num 3, pp 1053-1060, issn 0019-9567Article

Morphological differences in Neisseria meningitidis piliGREENBLATT, J. J; FLOYD, K; PHILIPPS, M. E et al.Infection and immunity. 1988, Vol 56, Num 9, pp 2356-2362, issn 0019-9567Article

Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shockQUAKYI, E. K; FRASCH, C. E; BULLER, N et al.The Journal of infectious diseases. 1999, Vol 180, Num 3, pp 747-754, issn 0022-1899Article

Measurements of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usageTSAI, C.-M; FRASCH, C. E; RIVERA, E et al.Journal of biological standardization. 1989, Vol 17, Num 3, pp 249-258, issn 0092-1157, 10 p.Article

Immunogenic and protective properties of meningococcal serotype 2a protein in the hen-embryo modelASHTON, F. E; RYAN, J. A; DIENA, B. B et al.Journal of medical microbiology. 1983, Vol 16, Num 4, pp 443-457, issn 0022-2615Article

Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein patternCAUGANT, D. A; MOCCA, L. F; FRASCH, C. E et al.Journal of bacteriology. 1987, Vol 169, Num 6, pp 2781-2792, issn 0021-9193Article

Analysis of damage to human ciliated nasopharyngeal epithelium by Neisseria meningitidisSTEPHENS, D. S; WHITNEY, A. M; MELLY, M. A et al.Infection and immunity. 1986, Vol 51, Num 2, pp 579-585, issn 0019-9567Article

Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus : construction, immunogenicity, and protective efficacy in a murine modelDEVI, S. J. N; HAYAT, U; FRASCH, C. E et al.Infection and immunity. 1995, Vol 63, Num 8, pp 2906-2911, issn 0019-9567Article

Page / 2